ArticleJournal of biomedical optics2025
Toward handheld optically guided biopsy combining diffuse reflectance spectroscopy and autofluorescence.
Article in Journal of biomedical optics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Significance: We aim to validate the technologies essential for a handheld, optically guided biopsy device designed to enhance the diagnostic yield and accuracy of percutaneous liver biopsy procedures. Aim: We aim to combine diffuse reflectance spectroscopy (DRS) and autofluorescence (AF) spectroscopy in a fiber-optic needle probe using mini spectrometers for the classification of tumor and healthy tissues. Approach: A fiber-optic needle probe combining DRS and AF spectroscopy, incorporating mini spectrometers to facilitate future integration into a biopsy actuator, was designed and built. This custom probe was used to measure healthy liver tissues and colorectal metastases in excised liver segments. A linear discriminant analysis was applied to the DRS and AF data to distinguish tumors from healthy tissues. Results: The miniaturized combined DRS and AF spectroscopy system could accurately distinguish tumors from healthy liver with a sensitivity of 95% and a specificity of 96% from a sample size of Conclusions: We demonstrate the feasibility of miniaturizing a combined DRS and AF spectroscopy system for the classification of tumor and healthy tissues. This validation supports the feasibility and further development of a handheld, optically guided biopsy device.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.